Special Encore Presentation: David Morgan, Nobilis Health, Oncolytics Biotech and BacTech Environmental

Today on the program Ellis speaks with Brad Thompson, CEO of Oncolytics Biotech Inc. trading as ONCY on the NASDAQ and ONC on the TSX. Oncolytics has developed a REOVIRUS called REOLYSIN that attacks cancer tumors while leaving healthy cells alone. He’ll chat with Harry Fleming, Executive Chairman of Texas based Nobilis Health Trading on the NYSE as HLTH. Nobilis has successfully developed a cadre of boutique surgical centers in Houston, Dallas and Phoenix. Ross Orr, President of Bactech Environmental, trading on the Otc as BCCEF and on the Canadian Stock Exchange as BAC will discuss the company’s proprietary bioleaching technology which remediates highly toxic tailing areas resulting from abandoned mining operations. David Morgan pontificates about war, religion, robotics and the marginalization of the American work force.